Skip to Content

A514 (Divalproex Sodium Delayed Release 500 mg)

Pill with imprint A514 is Yellow, Elliptical / Oval and has been identified as Divalproex Sodium Delayed Release 500 mg. It is supplied by Anchen Pharmaceuticals, Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; migraine prevention; epilepsy; cyclothymic disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A514

Divalproex Sodium Delayed Release

Imprint:
A514
Strength:
500 mg
Color:
Yellow
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Anchen Pharmaceuticals, Inc.
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
povidone
magnesium silicate
titanium dioxide
triethyl citrate
FD&C Yellow No. 5
ferric oxide red
cellacefate
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide